PLx Pharma Winddown Corp.
PLXPQ
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 52.18% | -4.01% | -60.62% | -203.23% | -524.83% |
| Total Depreciation and Amortization | -16.21% | -20.79% | -60.49% | -48.75% | -39.02% |
| Total Amortization of Deferred Charges | -97.86% | -99.09% | -99.50% | -96.41% | -88.70% |
| Total Other Non-Cash Items | -188.90% | -177.25% | -140.97% | 183.85% | 1,186.82% |
| Change in Net Operating Assets | 225.21% | 313.38% | 974.77% | 1,202.53% | 72.23% |
| Cash from Operations | -178.88% | -272.37% | -250.81% | -162.34% | -59.25% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -99.47% | 10.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -99.47% | 186.84% | 194.78% | 192.65% | 147.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | 83.33% | 58.33% |
| Issuance of Common Stock | -97.28% | -84.85% | -84.82% | 373.19% | 59,364.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 96.30% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.24% | -84.39% | -85.56% | 279.77% | 2,188.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.20% | -166.42% | -142.49% | 455.66% | 879.66% |